COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey

Author:

Huang Weifeng1,Shao Xiaoping1,Wagner Abram L.2ORCID,Chen Yan3,Guan Baichu4,Boulton Matthew L.2,Li Bingzhe4,Hu Linjie4,Lu Yihan4ORCID

Affiliation:

1. Department of Intensive Care Medicine, The Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China

2. Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA

3. Department of Clinical Pharmacology, The Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China

4. Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Reference33 articles.

1. World-Health-Organization. WHO coronavirus (COVID-19) dashboard. [cited 2021 Apr 30]Available from: https://covid19.who.int/

2. Our-World-in-Data. Coronavirus (COVID-19) vaccinations. [cited 2021 Apr 30]Available from: https://ourworldindata.org/covid-vaccinations

3. WHO. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination Sept 14, 2020. cited 2020 Sep 14; Available from: https://apps.who.int/iris/bitstream/handle/10665/334299/WHO-2019-nCoV-SAGE_Framework-Allocation_and_prioritization-2020.1-eng.pdf?sequence=1&isAllowed=y

4. The-National Academies-of-Sciences E,and Medicine. A framework for equitable allocation of vaccine for the novel coronavirus. [cited 2021 Apr 30]Available from: https://www.nationalacademies.org/our-work/a-framework-for-equitable-allocation-of-vaccine-for-the-novel-coronavirus

5. Government-of-the-People’s-Republic-of-China. Press conference of the joint prevention and control mechanism. Website in Chinese. cited 2020 Dec 19; Available from: http://www.gov.cn/xinwen/gwylflkjz140/index.htm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3